Physiological and clinical aspects in COVID-19
Journal: RUDN Journal of Medicine (Vol.24, No. 3)Publication Date: 2020-08-26
Authors : R. Satyanath; J. Sorout; S. Jayachandra; A. Gandhi; S. Kacker;
Page : 201-206
Keywords : Corona virus; COVID-19; MERS CoV; SARS-CoV; Therapies; COVID-19; MERS CoV; SARS-CoV;
Abstract
There is a new public health crises threatening globally with the emergence and spread of 2019 novel corona virus (COVID-19) or the severe acute respiratory syndrome corona virus 2 (SARS-CoV-2). In very recent decade we have seen endemic outbreaks in the form of Middle East respiratory syndrome coronavirus (MERS CoV) and severe acute respiratory syndrome related coronavirus (SARS-CoV). Now we again see the emergence of another serious outbreak due to a new strain called the SARS-CoV-2 virus. This SARS-CoV-2 initially presented as pneumonia of unknown etiology with group of symptoms including fever, dry cough and shortness of breath in a cluster of patients in December 2019 Wuhan, China. COVID-19 now has quickly became a health emergency now across worldwide. SARS-CoV-2 is a newly emerging human infectious corona virus that causes COVID-19, now this has been recognized as a pandemic by the World Health Organization (WHO) on 11th March, 2020. Because of the pathogenesis and proliferation pathways of COVID-19 are still unknown the development of vaccine was not developed yet and definitive treatment was not implemented. Therefore, in this article, new potential COVID-19 therapies are briefly reviewed. The world is in emergent need for searching of possible medications for COVID-19.
Other Latest Articles
- Relationship between Women’s Presence in Parliament and Higher Education in Iran
- Impact of UNDP’s Initiated Projects on Socio-Economic Development of Women: A Study of Rural Punjab, Pakistan
- Leadership Failure and Acute Youth Unemployment in Nigeria
- The Effect of Human Resources Capacity, Budget Planning, Political Budgeting, and Public Transparency on the APBD Documents and KUA-PPAS’s Synchronization in Musi Banyuasin District Government
- Large Business in Higher Levels of US Authority Example of D. Trump
Last modified: 2020-09-10 05:19:59